Alnylam Pharmaceuticals, Inc. · NASDAQ:ALNY

Arbuckle Stuart A received 671 Alnylam Pharmaceuticals, Inc. shares as an award (Form 4)

Traded May 20, 2026 · Filed May 22, 2026

On May 20, 2026, Arbuckle Stuart A (Director) received 671 Alnylam Pharmaceuticals, Inc. shares as an award, leaving 671 shares. Filed May 22, 2026 (Form 4).

Awarded
671 shares
Holding after
671 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 20, 2026Common StockAward671671Direct

Source

View original at SEC

Related